Cardinal Health Selected by the Ohio Department of Health for COVID-19 Vaccine Distribution

Cardinal Health has been selected by the Ohio Department of Health to support its efforts to distribute COVID-19 vaccines by arranging transportation within the state of Ohio.

Once a vaccine is available and Ohio receives doses for in-state distribution, Cardinal Health’s OptiFreight® Logistics* business will provide same-day delivery services to approximately 350 locations across 88 counties.

The state of Ohio currently expects initial vaccine doses to require special handling and temperature control, and OptiFreight® Logistics will leverage its expertise in managing the transportation of sensitive products to ensure safe, successful delivery.

“We are proud to provide our services to support our home state,” said Steve Mason, CEO of Medical segment, Cardinal Health. “A fully coordinated supply chain is critical to getting Americans safely vaccinated, and Cardinal Health is uniquely positioned to support Ohio’s vaccination efforts so we can collectively begin to put COVID-19 behind us.”

*A division of Cardinal Health, OptiFreight® Logistics provides freight management across the continuum of care, delivering total transportation management for the healthcare industry. As a premier comprehensive logistics management provider, OptiFreight® Logistics anticipates healthcare customers’ needs to help them optimize shipping costs through advanced analytics and integrated shipping solutions

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”